TMC114, a next-generation protease inhibitor, has demonstrated significant antiviral activity in multiple PI-experienced HIV patients currently failing PI therapy. In the 50 patient study, the median ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback